Literature DB >> 14515145

Structure and functions of tumor necrosis factor-alpha converting enzyme.

Renata Mezyk1, Monika Bzowska, Joanna Bereta.   

Abstract

Tumor necrosis factor-alpha converting enzyme (TACE) is the first described and best characterized secretase. In this review the structure and the possible roles for TACE are summarized. The substrate specificity and the regulation of TACE activity as well as redundancy and possible cooperations of distinct secretases are also discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14515145     DOI： 035003625

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN： 0001-527X            Impact factor:   2.149


  21 in total

1.  Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling.

Authors:  Marisa I Gómez; Maghnus O Seaghdha; Alice S Prince
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  Anthranilate derivatives as TACE inhibitors: docking based CoMFA and CoMSIA analyses.

Authors:  Malkeet Singh Bahia; Shravan Kumar Gunda; Shwetha Reddy Gade; Saikh Mahmood; Ravikumar Muttineni; Om Silakari
Journal:  J Mol Model       Date:  2010-03-28       Impact factor: 1.810

3.  Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation.

Authors:  Yuhui Wang; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.

Authors:  T Bohgaki; Y Amasaki; N Nishimura; M Bohgaki; Y Yamashita; M Nishio; K-I Sawada; S Jodo; T Atsumi; T Koike
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

5.  ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.

Authors:  Alvaro Gilsanz; Lorena Sánchez-Martín; María Dolores Gutiérrez-López; Susana Ovalle; Yesenia Machado-Pineda; Raquel Reyes; Guido W Swart; Carl G Figdor; Esther M Lafuente; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2012-09-30       Impact factor: 9.261

6.  Improving Donor Livers by Inhibiting TNF-α Production.

Authors:  Christopher P Zetzmann; O Rama Swamy; George E Loss; Humberto Bohorquez; Ari J Cohen
Journal:  Ochsner J       Date:  2010

7.  The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.

Authors:  Maria Dolores Gutiérrez-López; Alvaro Gilsanz; María Yáñez-Mó; Susana Ovalle; Esther M Lafuente; Carmen Domínguez; Peter N Monk; Isidoro González-Alvaro; Francisco Sánchez-Madrid; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

8.  LPA-producing enzyme PA-PLA₁α regulates hair follicle development by modulating EGFR signalling.

Authors:  Asuka Inoue; Naoaki Arima; Jun Ishiguro; Glenn D Prestwich; Hiroyuki Arai; Junken Aoki
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

9.  p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo.

Authors:  Matthias Canault; Daniel Duerschmied; Alexander Brill; Lucia Stefanini; Daphne Schatzberg; Stephen M Cifuni; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

10.  Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice.

Authors:  Lesca M Holdt; Joachim Thiery; Jan L Breslow; Daniel Teupser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-20       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.